GGrantIndex
Sort

15,842 grants matching pancreatic cancer

High-throughput screens to identify modulators of phospholipase C isozymes

$271,358
Qisheng Zhang · Univ Of North Carolina Chapel Hill · R01 · FY2013 · GM

Immunotherapy of mesothelin expressing tumors with lentiviral engineered T cells

$271,168
Carl H. June · University Of Pennsylvania · R01 · FY2007 · CA

Autoantibodies Against Glycopeptide Epitopes as Serum Biomarkers of Cancer

$271,036
Michael A Hollingsworth · University Of Nebraska Medical Center · U01 · FY2008 · CA

P-1: Regulation of Pancreatic Cancer Cell Production and Survival by GSK-3B

$271,033
Daniel D Billadeau · Mayo Clinic Rochester · P50 · FY2009 · CA

MULTIDISCRIPLINARY TRAINING IN DIGESTIVE DISEASES

$270,977
Mayo Clinic Coll Of Medicine, Rochester · T32 · FY2003 · DK

Large-scale Genetic Analyses of Human Cancer

$270,835
Victor E Velculescu · Johns Hopkins University · R01 · FY2014 · CA

Clinical protocols for the treatment of gastrointestinal cancer

$270,640
Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Synthetic and biological investigations of 2-aminoimidazole derived natural produ

$270,611
Ryan Edward Looper · University Of Utah · R01 · FY2013 · GM

Core B: Human Pancreas

$270,555
Walter Gwang-Up Park · Stanford University · P01 · FY2021 · CA

Core 2: Human Specimen and Organic Core (HSO Core)

$270,543
Herve Tiriac · Salk Institute For Biological Studies · P01 · FY2025 · CA

Pattern Analysis and Computational Biology Core

$270,507
Phillip Stafford · Translational Genomics Research Inst · P01 · FY2009 · CA

Molecular Pathogenesis of Digestive Diseases

$270,500
Harry Bernard Greenberg · Stanford University · P30 · FY2009 · DK

The molecular determinants of zinc uptake mediated by hZIP4

$270,466
Robert Edward Dempski · Worcester Polytechnic Institute · R01 · FY2014 · GM

TARGETING THE CASM ONCOGENE AS A NOVEL THERAPY FOR PANCREATIC CANCER

$270,405
David J Cole · Medical University Of South Carolina · R01 · FY2011 · CA

IMMUNOTHERAPY WITH CAR T CELLS

$270,400
Carl H. June · University Of Pennsylvania · R01 · FY2012 · CA

IMMUNOTHERAPY WITH CAR T CELLS

$270,400
Carl H. June · University Of Pennsylvania · R01 · FY2015 · CA

IMMUNOTHERAPY WITH CAR T CELLS

$270,400
Carl H. June · University Of Pennsylvania · R01 · FY2016 · CA

Metnase, PIKK, and RPA Roles in DNA Damage and Replication Stress Responses

$270,375
Jac A Nickoloff · Colorado State University · R01 · FY2016 · GM

Metnase, PIKK, and RPA Roles in DNA Damage and Replication Stress Responses

$270,367
Jac A Nickoloff · Colorado State University · R01 · FY2015 · GM

Enhanced CRAd for Pancreatic Cancer

$270,363
Masato Yamamoto · University Of Minnesota · R01 · FY2013 · CA

Metnase, PIKK, and RPA Roles in DNA Damage and Replication Stress Responses

$270,360
Jac A Nickoloff · Colorado State University · R01 · FY2014 · GM

The Role of COX-2 and PPAR-Gamma in Pancreatic Cancer

$270,281
Guido Erwin Michael Eibl · University Of California Los Angeles · R01 · FY2007 · CA

The role of p16INK4a in mammalian aging

$270,249
Norman Edward Sharpless · Univ Of North Carolina Chapel Hill · R01 · FY2008 · AG

Role of Nuclear Factor kappa Beta in Activity of BITC against Pancreatic Cancer

$270,240
Sanjay K Srivastava · Texas Tech University Health Scis Center · R01 · FY2007 · CA

Reactivity epitopes of ribonuclease III substrates

$270,204
Allen Whitall Nicholson · Temple Univ Of The Commonwealth · R01 · FY2007 · GM